Aquaretic Effect of Lixivaptan, an Oral, Non-Peptide, Selective V2 Receptor Vasopressin Antagonist, in New York Heart Association Functional Class II and III Chronic Heart Failure Patients - Concepedia

Concepedia

Publication | Closed Access

Aquaretic Effect of Lixivaptan, an Oral, Non-Peptide, Selective V2 Receptor Vasopressin Antagonist, in New York Heart Association Functional Class II and III Chronic Heart Failure Patients

130

Citations

21

References

2006

Year

William T. Abraham, Alireza A. Shamshirsaz, Kim McFann, Ron M. Oren, Robert W. Schrier

Journal of the American College of Cardiology

Aquaretic EffectHeart FailureCardiovascular DiseaseMedicinePhysiologyPharmacotherapyCardiovascular FunctionPharmacologyCardiologyDiastolic Function

References

	Year	Citations

Page 1